Bigelow Investment Advisors LLC Has $505,000 Holdings in iShares Biotechnology ETF $IBB

Bigelow Investment Advisors LLC trimmed its position in iShares Biotechnology ETF (NASDAQ:IBB) by 48.1% in the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 3,498 shares of the financial services provider’s stock after selling 3,242 shares during the quarter. Bigelow Investment Advisors LLC’s holdings in iShares Biotechnology ETF were worth $505,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors have also recently bought and sold shares of the company. Brighton Jones LLC acquired a new position in shares of iShares Biotechnology ETF in the 4th quarter valued at $201,000. Focus Partners Advisor Solutions LLC bought a new stake in iShares Biotechnology ETF in the first quarter valued at about $257,000. AQR Capital Management LLC acquired a new position in iShares Biotechnology ETF in the first quarter worth about $455,000. Millennium Management LLC lifted its stake in iShares Biotechnology ETF by 140.8% during the first quarter. Millennium Management LLC now owns 41,676 shares of the financial services provider’s stock worth $5,330,000 after purchasing an additional 143,893 shares during the period. Finally, NewEdge Advisors LLC lifted its stake in iShares Biotechnology ETF by 8.7% during the first quarter. NewEdge Advisors LLC now owns 14,984 shares of the financial services provider’s stock worth $1,917,000 after purchasing an additional 1,195 shares during the period. 62.45% of the stock is owned by institutional investors.

iShares Biotechnology ETF Trading Up 0.1%

IBB stock opened at $169.00 on Monday. iShares Biotechnology ETF has a 1-year low of $107.43 and a 1-year high of $174.40. The business’s 50 day moving average is $166.71 and its 200-day moving average is $148.55.

iShares Biotechnology ETF Increases Dividend

The business also recently disclosed a quarterly dividend, which was paid on Friday, December 19th. Shareholders of record on Tuesday, December 16th were paid a dividend of $0.1831 per share. This is an increase from iShares Biotechnology ETF’s previous quarterly dividend of $0.08. This represents a $0.73 annualized dividend and a yield of 0.4%. The ex-dividend date was Tuesday, December 16th.

About iShares Biotechnology ETF

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.